Literature DB >> 18043932

Clinical subgroups and antifungal susceptibilities in fungal culture-positive patients with chronic rhinosinusitis.

Selim S Erbek1, Kivanc Serefhanoglu, Seyra Erbek, Muge Demirbilek, Fusun Can, Erkan Tarhan, Hale Turan, Ozcan Cakmak.   

Abstract

The goal of this study was to investigate clinical characteristics of chronic rhinosinusitis (CRS) in patients with positive fungal cultures. Fungal cultures were taken from 55 CRS patients and 20 healthy volunteers. Susceptibilities of isolated fungi to fluconazole, amphotericin B, itraconazole, voriconazole, and caspofungin were determined in CRS patients. Fungi grew in the cultures from 44 (80%) CRS patients and 17 (85%) healthy volunteers. Of the patients with positive fungal cultures, 5 (11.3%) had fungal hypersensitivity (FH), and 21 (47.7%) had eosinophilic mucin (EM). Fungal culture-positive patients with EM were more likely to be associated with presence of polyps and higher CT scores than those without EM (P < 0.05). All the patients with FH had EM and polyps, and CT scores of those patients were highest. The sensitivity rates of fungal isolates were 97.8% for amphotericin B, caspofungin, and voriconazole; 74.4% for itraconazole; and 6.4% for fluconazole. The presence of EM with or without FH leaded to more extended CRS, but a part of positive fungal cultures were together with EM in patients with CRS. Sensitivity to antifungal agents, except fluconazole, was high. Because many factors can contribute to the pathogenesis of CRS, medical treatment should be considered on a case-by-case basis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18043932     DOI: 10.1007/s00405-007-0542-3

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  23 in total

1.  Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis.

Authors:  Jens U Ponikau; David A Sherris; Hirohito Kita; Eugene B Kern
Journal:  J Allergy Clin Immunol       Date:  2002-12       Impact factor: 10.793

2.  'Eosinophilic fungal rhinosinusitis': a common disorder in Europe?

Authors:  Hannes Braun; Walter Buzina; Kurt Freudenschuss; Alfred Beham; Heinz Stammberger
Journal:  Laryngoscope       Date:  2003-02       Impact factor: 3.325

Review 3.  Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology.

Authors:  Michael S Benninger; Berrylin J Ferguson; James A Hadley; Daniel L Hamilos; Michael Jacobs; David W Kennedy; Donald C Lanza; Bradley F Marple; J David Osguthorpe; James A Stankiewicz; Jack Anon; James Denneny; Ivor Emanuel; Howard Levine
Journal:  Otolaryngol Head Neck Surg       Date:  2003-09       Impact factor: 3.497

4.  Treatment of allergic fungal sinusitis with high-dose itraconazole.

Authors:  B Manrin Rains; Corey W Mineck
Journal:  Am J Rhinol       Date:  2003 Jan-Feb

5.  Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial.

Authors:  Jens U Ponikau; David A Sherris; Amy Weaver; Hirohito Kita
Journal:  J Allergy Clin Immunol       Date:  2005-01       Impact factor: 10.793

6.  The diagnosis and incidence of allergic fungal sinusitis.

Authors:  J U Ponikau; D A Sherris; E B Kern; H A Homburger; E Frigas; T A Gaffey; G D Roberts
Journal:  Mayo Clin Proc       Date:  1999-09       Impact factor: 7.616

7.  Treatment of chronic rhinosinusitis with high-dose oral terbinafine: a double blind, placebo-controlled study.

Authors:  D W Kennedy; F A Kuhn; D L Hamilos; S J Zinreich; D Butler; G Warsi; P J Pfister; A Tavakkol
Journal:  Laryngoscope       Date:  2005-10       Impact factor: 3.325

8.  Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis.

Authors:  Fenna A Ebbens; Glenis K Scadding; Lydia Badia; Peter W Hellings; Mark Jorissen; Joaquim Mullol; Alda Cardesin; Claus Bachert; Thibaut P J van Zele; Marcel G W Dijkgraaf; Valerie Lund; Wytske J Fokkens
Journal:  J Allergy Clin Immunol       Date:  2006-11       Impact factor: 10.793

9.  Detection of fungal organisms in eosinophilic mucin using a fluorescein-labeled chitin-specific binding protein.

Authors:  Matthew J Taylor; Jens U Ponikau; David A Sherris; Eugene B Kern; Thomas A Gaffey; Gail Kephart; Hirohito Kita
Journal:  Otolaryngol Head Neck Surg       Date:  2002-11       Impact factor: 3.497

Review 10.  Pathogenesis of chronic rhinosinusitis.

Authors:  David W Kennedy
Journal:  Ann Otol Rhinol Laryngol Suppl       Date:  2004-05
View more
  3 in total

1.  Postoperative application of amphotericin B nasal spray in chronic rhinosinusitis with nasal polyposis, with a review of the antifungal therapy.

Authors:  I Gerlinger; A Fittler; F Fónai; A Patzkó; A Mayer; L Botz
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-10-25       Impact factor: 2.503

2.  Are systemic voriconazole and caspofungin ototoxic? An experimental study with rats.

Authors:  Emine Aydın; Filiz Aydoğan; Eren Taştan; Ayşe Iriz; Gökhan Karaca; Ilknur Haberal Can
Journal:  Clin Exp Otorhinolaryngol       Date:  2012-08-27       Impact factor: 3.372

3.  Sinus aspergilloma in rheumatoid arthritis before or during tumor necrosis factor-alpha antagonist therapy.

Authors:  Ariane Leboime; Jean-Marie Berthelot; Yannick Allanore; Lama Khalil-Kallouche; Philippe Herman; Philippe Orcel; Frédéric Lioté
Journal:  Arthritis Res Ther       Date:  2009-11-03       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.